News

British Association of Head and Neck Oncologists (BAHNO) conference, May 2019

Professor Steve Thomas attended the BAHNO annual scientific meeting in London. He gave a talk covering the reasons for setting up H&N5000, highlighting important results and future plans. There was a great interest in extending the resource and completing a further follow-up.

 

Voyager study meeting, Tennessee, May 2019

Professor Ness and Dr Pring attended the Voyager study meeting in Memphis, Tennessee. Voyager is an international project looking at the role of germline and somatic DNA mutations in oral and oropharyngeal cancers. The first samples from the H&N5000 study have now been sent over to the laboratory in Memphis for analysis. 

 

German Cancer Research Centre (DKFZ) visit 20 - 30 April 2019, Bristol

Tim Waterboer, Michael Pawlita, Lea Schroeder and Julia Simon from DKFZ, the German Cancer Research Centre, visited Bristol to discuss our ongoing collaboration on a project using serology to identify head and neck cancers that are driven by human papilloma virus (HPV). The H&N5000 team are identifying any additional samples that can be allocated to this exciting project.

 

H&N5000, DKFZ and ICEP collaboration meeting 29 April 2019, Bristol

Representatives from the Bristol University ICEP (Intergrative Cancer Epidemiology Programme) team, DKFZ (German Cancer Research Centre) and H&N5000 met to share ideas and discuss possible future collaborations. Researchers gave a series of short talks followed by discussion on ideas for future projects.

 

Last Data Capture Form and final data queries

All the Follow-up Study data capture forms and all data queries issued have now been returned. We are completing some final cleaning and coding which we hope to finish by the end of June. We would like to thank all of the site teams for their help and support with the data collection.

 

HEADSpAcE study meeting Lyon, France on 1-2 March 2019

Professor Ness, Dr Pring and Professor Thomas attended the first annual meeting of the HEADSpAcE study. HEADSpAcE aims to look in to the reasons for poor prognosis of head and neck cancers and predictors of prognosis. The project is funded by the European Union and brings together an international consortium of 15 organisations across Europe and South America.

 

PredicTR-2 Study Meeting 25 January 2019

Professor Ness, Dr Pring and Professor Thomas attended the PredicTR-2 study meeting held in Birmingham. H&N5000 is working closely with the PredictR team on a tissue based biomarker study that aims to predict the response to different treatments for patients diagnosed with oropharyngeal cancer.